FDA Launches One-Day Inspection Pilot Program to Enhance Oversight

The U.S. Food and Drug Administration (FDA) has initiated a pilot program involving one-day inspectional assessments at various facilities. The aim of this initiative is to bolster risk-based oversight and broaden the scope of inspection coverage across different programs.

The FDA designed the pilot to support their oversight duties. The program will assess facilities in a condensed timeframe. This approach allows for a more efficient allocation of resources and a wider reach in monitoring various sectors.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: May 7, 2026

Author

GOAI